The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 77,941 shares of the medical device company's stock after purchasing an additional 5,940 shares during the period. Thrivent Financial for Lutherans' holdings in Cooper Companies were worth $7,165,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in shares of Cooper Companies in the 4th quarter valued at about $64,826,000. Victory Capital Management Inc. increased its position in shares of Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after buying an additional 573,908 shares during the period. Wealthfront Advisers LLC lifted its position in Cooper Companies by 4,594.1% in the fourth quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company's stock worth $52,383,000 after buying an additional 557,673 shares during the last quarter. Finally, Alecta Tjanstepension Omsesidigt purchased a new position in Cooper Companies during the fourth quarter worth $49,550,000. 24.39% of the stock is owned by institutional investors.

Remove Ads

Cooper Companies Stock Up 1.3 %

COO stock traded up $1.12 during trading on Thursday, hitting $84.98. 2,256,824 shares of the company's stock traded hands, compared to its average volume of 1,296,067. The firm has a market capitalization of $16.99 billion, a P/E ratio of 43.58, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 1 year low of $77.05 and a 1 year high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $89.66 and a two-hundred day simple moving average of $97.62.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Morgan Stanley cut their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Citigroup dropped their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.